Oct 2026
Circulating and tumor microenvironment immunomarkers associate with immunotherapy efficacy in advanced bladder urothelial carcinoma: an exploratory multicenter study integrating genomic and immunophenotypic profiling.
AIMS To elucidate the efficacy-predictive values of immunomarkers in both peripheral blood and tumor tissue in patients with advanced bladder-urothelial-carcinoma (aBUC) undergoing first-line immunotherapy. PATIENTS AND METHODS In previously untreated aBUC, T-cell subclusters and PD-L1 expression were determined usin...
Sha Liu, Jun-Jun Lu, Zhaojie Lyu et al.
· Immunotherapy · 0 citations